KB Home
KBH
Ecopetrol
EC
Petroleo Brasileiro SA Petrobras
PBR
Vale SA
VALE
Taylor Morrison Home
TMHC
US Stock MarketDetailed Quotes
JSPR Jasper Therapeutics
- 4.680
- -0.310-6.21%
Close Mar 26 16:00 ET
- 4.750
- +0.070+1.50%
Post 17:42 ET
70.30MMarket Cap-0.96P/E (TTM)
5.085High4.652Low231.49KVolume5.000Open4.990Pre Close1.10MTurnover2.34%Turnover RatioLossP/E (Static)15.02MShares31.01052wk High1.14P/B46.38MFloat Cap4.55052wk Low--Dividend TTM9.91MShs Float188.800Historical High--Div YieldTTM8.68%Amplitude3.862Historical Low4.767Avg Price1Lot Size
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Jasper Therapeutics Stock Forum
Can Jasper Therapeutics' Briquilimab Transform Chronic Urticaria Treatment? New Clinical Data Revealed
Jasper Therapeutics Presents Clinical and Preclinical Briquilimab Data at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
Saturday, 1st March at 12:45 pm
REDWOOD CITY, Calif., March 01, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit to address mast cell driven diseases such as chro...
Jasper's Briquilimab Takes Center Stage: 6 Key Data Presentations to Reveal Treatment Breakthrough at AAAAI 2025
Why is this so cheap if they rate it Strong Buy $62.78
1. NFA (Not Financial Advice!)
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NE...
No comment yet